Medidata unveiled its next-generation AI-powered imaging solution at ASCO 2026, enhancing clinical trial efficiency by speeding up protected health information redaction by 32% and achieving over 97% accuracy in anatomy verification. This technology addresses key challenges in oncology trials, where imaging is critical for assessing tumor progression, and offers rapid quality control feedback to prevent delays. Medidata plans to expand these AI capabilities next year with features like enhanced tumor detection and streamlined image transfers across a network of 1,000+ U.S. hospitals, aiming to accelerate clinical breakthroughs and improve patient outcomes.
Citytv has announced the renewal of its popular series Hudson & Rex for a new 12-episode season, with production beginning in June 2026 in St. John's, Newfoundland. John Reardon returns as detective Charlie Hudson, reuniting with his canine partner R...
Citytv has announced the renewal of its popular series Hudson & Rex for a new 12-episode season starting production in June 2026 in St. John's, Newfoundland. John Reardon returns as Detective Charlie Hudson, reuniting with his canine partner Rex, alo...
A NordLayer report reveals that 82% of IT professionals experienced web-based security incidents in the past year, with half describing the impact as moderate or severe. Increased use of BYOD policies, remote work, and SaaS tools expands attack surfa...
CredFin, Inc. has partnered with The Agent Underground, led by Rob Thomas, to help independent insurance agents access capital for acquisitions and growth amid AI-driven industry disruption. With AI threatening traditional agent roles and acceleratin...
BrainStorm Cell Therapeutics has appointed Peter J. Pitts, a former FDA Associate Commissioner, to its Board of Directors as the company prepares to start its Phase 3b ENDURANCE trial for its ALS therapy NurOwn. This trial is notable for being the fi...
